SUSAN GUERRA: Open Payments
NPI 1003021700 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,803 in 100 payments from 17 companies in 2025. Trend: 2023 $932 · 2024 $1,569 · 2025 $1,803
Food & beverage: $1,704Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $397 |
| Janssen Biotech, Inc. | 13 | $300 |
| ABBVIE INC. | 25 | $294 |
| Amgen Inc. | 9 | $241 |
| PFIZER INC. | 13 | $182 |
| Galderma Laboratories, L.P. | 4 | $67 |
| Lilly USA, LLC | 3 | $53 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| LEO Pharma Inc. | 2 | $39 |
| UCB, Inc. | 2 | $38 |
Products named: COSENTYX, TREMFYA, OTEZLA, SKYRIZI, CIBINQO, Rhapsido, NEMLUVIO, RINVOQ.
Industry payments across NJ — which companies pay providers there.
